These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17362218)

  • 1. Workplace drug testing and worker drug use.
    Carpenter CS
    Health Serv Res; 2007 Apr; 42(2):795-810. PubMed ID: 17362218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between employer health insurance characteristics and the provision of employee assistance programs.
    Zarkin GA; Garfinkel SA
    Inquiry; 1994; 31(1):102-14. PubMed ID: 8168905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and alcohol in the workplace.
    Conry PB
    AAOHN J; 1991 Oct; 39(10):461-5. PubMed ID: 1930379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of occupational health services in workplace drug testing.
    Lillsunde P; Mukala K; Partinen R; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):103-6. PubMed ID: 17467212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Finnish legislation on workplace drug testing.
    Lamberg ME; Kangasperko R; Partinen R; Lillsunde P; Mukala K; Haavanlammi K
    Forensic Sci Int; 2008 Jan; 174(2-3):95-8. PubMed ID: 17498899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse and the uninsured worker in the United States.
    Galvin DM; Miller TR; Spicer RS; Waehrer GM
    J Public Health Policy; 2007; 28(1):102-17. PubMed ID: 17363941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Types of drug-testing programmes in the workplace.
    Mørland J
    Bull Narc; 1993; 45(2):83-113. PubMed ID: 7920543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finnish guidelines for workplace drug testing.
    Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug testing in the workplace.
    Osterloh J
    Occup Med; 1990; 5(3):617-32. PubMed ID: 2218805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.